Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
American Express Global Corporate Travel Advisors provides end-to-end corporate travel and meetings program management.
Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.
Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include Artiva Biotherapeutics, Avalo Therapeutics, Windward Bio, American Express Global Corporate Travel Advisors, Exo. These companies were founded in 2020 or later.